References
- Parnetti, L., Senin, U. and Mecocci, P. : Cognitive enhancement therapy for Alzheimer's disease : The way forward. Drugs 53, 752 (1997).
- Brinton, R. D. and Yamazaki, R. S. : Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharm. Res. 15, 386 (1998).
- Park, Y. M., Jeon, Y. M., Kwon, G. C., Koo, S. H. and Park, J. W. : Analysis of apolipoprotein E genotypes in several demential diseases. Korean J. Clin. Pathol. 19, 642 (1999).
- Karran, E., Mercken, M. and Strooper, B. D. : The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug. Discov. 10, 698 (2011).
- Hardy, J. A. and Higgins, G. A. : Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184 (1992).
- Alonso, A. C., Grundke-lqbal, I. and Iqbal, K. : Alzheimer's disease hyperphosphorylated Tau sequesters normal Tau into tangles of filaments and disassembles microtubules. Nature Med. 2, 783 (1996).
- Alonso, A. C., Grundke-lqbal, I. and Iqbal, K. : Abnormally phosphorylated Tau from Alzheimer's dosease brain depolymerizes microtubules. Neurobiol. Aging 15, s37 (1994).
- Behl, C. : Alzheimer's disease and oxidative stress : implications for novel therapeutic approaches. Prog. Neurobiol. 57, 301 (1999).
- Whitehouse, P. J., Price, D. J., Struble, R. G., Clark, A. W., Coyle, T. J. and Detol, M. R. : Alzheimer's disease and senile dementia : loss of neuros in the basal forebrain. Science 215, 1237 (1982).
- Roberson, M. R., Kolasa, K., Parsons, D. S. and Harrell, L. E. : Cholinergic denevation and sympathetic ingrowth result in presistent changes in hippocampal muscarinic receptor. Neurosecience 80, 413 (1997).
- Barril, X., Orozco, M. and Luque, F. J. : Towards improved acetylcholinesterase inhibitor : a structural and computational approach. Mini. Rev. Med. Chem. 1, 255 (2001).
- Selkoe, D. J. : Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, 23 (1999).
- Han, S. H. : Novel pharmacotherapies for Alzheimer's disease. J. Korean Med. Assoc. 52, 1059 (2009).
-
Lorenzo, A. and Yankner, B. A. :
$\beta$ -Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Nati. Acad. Sci. 91, 12243 (1994). - Lee, D. W., Huh, Y. S. and Kim, K. W. : Evidence-based treatment of Alzheimer's disease. J. Korean Med. Assoc. 52, 417 (2009).
- Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. and Weller, R. O. : Neuropathology of human alzheimer disease after immunization with amyloid-beta peptide: A case report. Nat. Med. 9, 448 (2003).
-
Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A. and Hock, C. : Subacute meningoencephalitis in a subset of patients with AD after A
$\beta$ 42 immunization. Neurology 61, 46 (2003). - Min, S. K. and Hong, C. H. : Korean traditional medicines as novel drugs for neuropsychiatric disorders. Korean J. Psychopharmacol. 18, 5 (2007).
- Heo, J. H., Park, J. G., Cheon, H. J., Kim, Y. S., Kang, S. S., Hung, T. M., Bea, K. H. and Lee, S. M. : Hepatoprotective activities of gomisin A and gomisin N. Kor. J. Phamacogn. 37, 294 (2006).
- Lee, J. S. and Lee, S. W. : Effects of water extracts in fruits of omija (Schizandra chinensis Baillon) on alchol metabolism. Korean J. Dietary Culture 5, 259 (1990).
- Jang, E. H., Pyo, Y. H. and Ahn, M. S. : Antioxidant effect of omija (Schizandra chinensis Baillon) extracts. Korean J. Soc. Food Sci. 12, 372 (1996).
- Kim, H. K., Na, G. M., Ye, S. H. and Han, H. S. : Extraction characteristics and antioxidative activity of Schizandra chinensis extracts. Korean J. Food Culture 19, 484 (2004).
- Hong, K. H., Nam, E. S. and Park, S. I. : Effect of Omija (Schizandra chinensis) extract on the growth inhibition of food borne pathogens in yoghurt. Korean J. Food Sci. Ani. Resour. 23, 342 (2003).
- Ko, B. S., Park, S. K., Choi, S. B., Jun, D. W., Choi, M. K. and Park, S. M. : A study on hypoglycemic effects of crude extracts of Schizandrae fructus. J. Korean Soc. Appl. Biol. Chem. 47, 258 (2004).
- Kim, H. C. : Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol. Res. 27, 287 (2005).
- Hancke, J. L., Burgos, R. A. and Ahumada, F. : Schisandra chinensis (Turcz.) Baill. Fitoterapia. 70, 451 (1999).
- Kim, M. J. and Park, E. J. Antioxidative and antigenotoxic effect of Omija (Schizandra chinensis B.) extracted with various solvent. J. Korean Soc. Food Sci. Nutr. 39, 487 (2010).
- Ohkura, Y., Mizoguchi, Y., Yamamoto, S. and Morisawara, S. : Inhibitory effect of TJN-101 ((+)-(6S,7S,R-biar)-5,6,7,8-tetrahydro- 1,2,3,12-tetramethoxy-6,7-dimethyl-10,11-methylenedioxy-6- dibenzo[a,c]cyclooctenol) on immunologically induced liver injuries. Jpn. J. Pharmacol. 44, 179 (1987).
- Yamamda, S., Murawaki, Y. and Kawasaki, H. : preventive effect of gomisin A, a lignan component of schizandra fruits, on acetaminophen-induced hepatotoxicity in rats. Biochem. Pharmacol. 46, 1081 (1993).
- Maeda S., Takeda, S., Miyamoto, Y., Aburada, M. and Harada,M. : Effect of gomisin A on liver functions in hepatotoxic chemicals-treated rats. Jpn. J. Phamacol. 38, 347 (1985).
- Kim, D. H., Hung, T. M., Bae, K. H., Jung, J. W., Lee, S. J., Yoon, B. H., Cheong, J. H., Ko, K. H. and Ryu, J. H. : Gomisin A improves scopolamine-induced memory impairment in mice. Eur. J. Pharmacol. 542, 129 (2006).
- Liu, G. T. : Pharmacological actions and clinical use of Fructus schizandrea. Chin. Med. J. 102, 740 (1989).
- Lu, H. and Liu, G. T. : Effect of dibenzo[a, c]cyclooctene lignans isolation from Fructus schizandrea on lipid peroxidation and antioxidative enzyme activity. Chem. Biol. Interact. 78, 77 (1991).
- Liu, K. T. and Lesca, P. : Pharmacological properties of dibenzo[a, c]cyclooctene derivatives isolation from Fructus schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotic metabolism and mutagenicity. Chem. Biol. Interact. 3, 301 (1982).
- Ohtaki, Y., Nomura, M., Hida, T., Miyamoto, K., Kanitani, M., Aizawa, T. and Aburada M. : Inhibition by gomisin A, a lignan compound, of hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene in rat. Biol. Pharm. Bull. 6, 808 (1994).
- Mak, D. H., Ip, S. P., Li, P. C., Poon, M. K. and Ko, K. M. : Effects of schisandrin B and alpha-tocopherol on lipid peroxidation, in vitro and in vivo. Mol. Cell. Biochem. 2, 161 (1996).
- Choi, E. O., Lee, B. S., Park, Y. S., Seo, E. O. and Chung, B. W. : Extraction condition from Schizandra chinensis Baillon for beverage development of high Schizandrin concentration. Korean J. Biotechnol. Bioeng. 23, 271 (2008).
-
Yang, S. P., Bae, D. G., Kang, H. J., Gwag, B. J., Gho, Y. S. and Chae, C. B. : Co-accumulation of vascular endothelial growth factor with
$\beta$ -amyloid in the brain of patients with Alzheimer's disease. Neurobiol. Aging 25, 283 (2004). - Sondell, M., Lundborg, G. and Kanje, M. : Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731 (1999).